MARKET

ARKG

ARKG

ARK Genomic Revolution ETF
BATS

Real-time Quotes | Provided by Morningstar

74.73
+0.01
+0.01%
After Hours: 74.70 -0.03 -0.04% 19:52 11/25 EST
OPEN
75.12
PREV CLOSE
74.72
HIGH
75.33
LOW
74.31
VOLUME
1.02M
TURNOVER
--
52 WEEK HIGH
78.37
52 WEEK LOW
24.00
TOTAL ASSET
2.78B
YTD YIELD
73.37%
1D
5D
1M
3M
1Y
5Y
News
Performance
Cathie Wood Adds Longview Acquisition SPAC Ahead Of Deal With Butterfly Network
One of the top performing ETF managers and most-watched names in the industry took a new stake in a SPAC. What Happened: Cathie Wood on Monday took an initial stake in Longview Acquisition Corp (NYSE: LGVW).
Benzinga · 2d ago
Hedge-Fund Copycats Rally as Academics Defend Embattled Strategy
Investing products designed to bring hedge-fund strategies to the masses are on course for one of their best months in more than a decade, as the latest research argues the oft-maligned trades have robust foundations.
Bloomberg · 2d ago
Triple-Leveraged Products Killed by Oil Crash Rise From Dead
Just months after they were killed off in the historic oil collapse, WisdomTree is relaunching leveraged exchange-traded products tied to the commodity in a remarkable comeback even by 2020 standards.
Bloomberg · 2d ago
A $683 Billion Rally Hauls Canadian Stocks Out of Slump
Seven months after starting a bull market rally, Canada’s stock market has finally erased the last of its pandemic-driven losses.
Bloomberg · 3d ago
Two Giant Trades Hand $16 Billion Bond ETF Worst Week Since 2014
Bloomberg · 3d ago
Gold Steadies After Run of Losses With ETF Drawdowns in Focus
Bloomberg · 6d ago
A Trade That Surged 40% on Pandemic Misery Risks Stalling
Even as the world nears a vaccine and the economic outlook brightens, a booming trade that bets on bonds from some of the companies hit hardest by the pandemic is at risk of stalling.
Bloomberg · 6d ago
Options Are Signaling a More Placid Stock Market Through Yearend
U.S. equity investors who have endured some of the widest price swings on record amid the worst pandemic in modern times could be in for a respite as 2020 comes to a close.
Bloomberg · 6d ago
More
No Data
Learn about the latest financial forecast of ARKG. Analyze the recent business situations of ARK Genomic Revolution ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
2.4678%
--
3-Month
23.9446%
--
6-Month
65.8488%
--
1-Year
73.3671%
--
3-Year
36.0563%
--
5-Year
25.3333%
--
Since Inception
21.9419%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
ARK Genomic Revolution ETF
Risk
Low risk
Inception Date
2014-10-30
Benchmark
NASDAQ Composite CR
Advisor Company
ARK ETF Trust
Custodian
The Bank of New York Mellon
Manager
Catherine D. Wood